Three Norwegian health workers who recently received the AstraZeneca vaccine against COVID-19 are being treated in hospital for bleeding, blood clots and a low platelet count, Norwegian health authorities said on Saturday. Norway suspended the vaccine on Thursday. after a similar step through Denmark. Iceland later followed suit. “We do not know if the cases were linked to the vaccine,” said Sigurd Hortemo, a senior doctor at the Norwegian Medicines Agency, at a news conference with the Norwegian Institute of Public Health. All three individuals were under 50 years of age. European drug regulator EMA would investigate the three incidents, Hortemo added. “They have very unusual symptoms: bleeding, blood clots and a low platelet count,” said Steinar Madsen, medical director at the Norwegian Medicines Agency. NRK. “They are quite ill … We take it very seriously,” he said, adding that the authorities were notified of the cases on Saturday.
cnxps.cmd.push (function () {cnxps ({playerId: ’36af7c51-0caf-4741-9824-2c941fc6c17b’}). deliver (‘4c4d856e0e6f4e3d808bbc1715e132f6’);});
if (window.location.pathname.indexOf (“656089”)! = -1) {console.log (“hedva connatix”); document.getElementsByClassName (“divConnatix”)[0].style.display = “none”;}AstraZeneca was not immediately available for comment. Prior to the relocation of Denmark and Norway, Austria stopped using a number of AstraZeneca shots while investigating the death from coagulation disorders and a disease due to pulmonary embolism. EMA said on Thursday that the benefits of the vaccine outweigh the risks and Europe is struggling to accelerate the explosion of vaccines following delivery delays of Pfizer and AstraZeneca, even as an increase in cases amid a more contagious virus variant, new barriers in countries such as Italy and France.